bupivacaine has been researched along with Lung Diseases in 12 studies
Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
Lung Diseases: Pathological processes involving any part of the LUNG.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 5 (41.67) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Medina, M | 1 |
Foiles, SR | 1 |
Francois, M | 1 |
Asche, CV | 1 |
Ren, J | 1 |
Mueller, DK | 1 |
Anderson, RC | 1 |
Amr, YM | 1 |
Yousef, AA | 1 |
Alzeftawy, AE | 1 |
Messbah, WI | 1 |
Saber, AM | 1 |
Grannis, FW | 1 |
Alptekin, H | 1 |
Sahin, M | 1 |
Esme, H | 1 |
Apiliogullari, B | 1 |
Duran, FM | 1 |
Yoldas, B | 1 |
Bekci, TT | 1 |
Guha, A | 1 |
Scawn, ND | 1 |
Rogers, SA | 1 |
Pennefather, SH | 1 |
Russell, GN | 1 |
Ngan-Kee, WD | 1 |
Lee, BB | 1 |
Jayr, C | 1 |
Thomas, H | 1 |
Rey, A | 1 |
Farhat, F | 1 |
Lasser, P | 1 |
Bourgain, JL | 1 |
Bimston, DN | 1 |
McGee, JP | 1 |
Liptay, MJ | 1 |
Fry, WA | 1 |
Pedersen, T | 1 |
Viby-Mogensen, J | 1 |
Ringsted, C | 1 |
Eng, J | 1 |
Sabanathan, S | 1 |
Cuschieri, RJ | 1 |
Morran, CG | 1 |
Howie, JC | 1 |
McArdle, CS | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of the Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion on the Quality of Postoperative Recovery in Patients Undergoing VATS Lobectomy[NCT05930405] | 252 participants (Anticipated) | Interventional | 2023-10-01 | Recruiting | |||
Role of Scheduled Intravenous Acetaminophen for Postoperative Pain Management in an Enhanced Recovery After Surgery (ERAS) Population: A Prospective, Randomized, Double-Blind and Placebo-Controlled Clinical Trial[NCT03198871] | Phase 4 | 180 participants (Actual) | Interventional | 2018-05-24 | Completed | ||
The Effect of Foot Massage on Pain, Sleep Quality and Early Discharge in Patients Undergoing Spinal Surgery[NCT05354830] | 70 participants (Actual) | Interventional | 2022-05-01 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Number of patients who score greater than a 4 on the 0-8 point ICDSC scale to assess delirium scores. 8 separate levels of signs for delirium assessed (1. altered level of consciousness, 2. inattention, 3. disorientation, 4. hallucination, delusion, or psychosis, 5. psychomotor agitation or retardation, 6. inappropriate speech or mood, 7. sleep-wake cycle disturbance, 8. symptom fluctuation), with 0 points awarded when patient does not exhibit above signs of delirium and 1 point awarded per confirmed sign of delirium. Score then totaled, 0 = normal, 1-3 = subsyndromal delirium, 4-8 = delirium. (NCT03198871)
Timeframe: The delirium scores will first be measured every 12 hours for 72 hours after surgery.
Intervention | Participants (Count of Participants) |
---|---|
Acetaminophen Injectable Product | 0 |
Sodium Chloride 0.9%, Intravenous | 0 |
If the patient is readmitted to the hospital after being fully discharged, the event will be recorded. (NCT03198871)
Timeframe: From the time of consent until 30 days post-operatively
Intervention | Participants (Count of Participants) |
---|---|
Acetaminophen Injectable Product | 9 |
Sodium Chloride 0.9%, Intravenous | 10 |
Number of patients with unsatisfactory pain relief defined as average numeric rating scale (NRS) more than 5 will be compared between the two groups. This may include patients using IVPCA for pain relief during the first 48 hours postoperative. (NCT03198871)
Timeframe: PACU admission every thirty minutes until discharge to the floor and thereafter every four hours for first 24-hour, then every six hours until 48 hours and then every twelve hours until 72 hours postoperatively.
Intervention | Participants (Count of Participants) |
---|---|
Acetaminophen Injectable Product | 33 |
Sodium Chloride 0.9%, Intravenous | 42 |
The time it takes for the patient to successfully ambulate post-surgery will be measured. (NCT03198871)
Timeframe: From date of PACU admission until the date of first documented ambulation, assessed up to 72 hours postoperatively
Intervention | hours (Median) |
---|---|
Acetaminophen Injectable Product | 18.82 |
Sodium Chloride 0.9%, Intravenous | 17.38 |
The time it takes for the first bowel movement postoperatively will be measured. (NCT03198871)
Timeframe: From time patient left operating room until the time of first documented bowel movement, assessed up to hospital discharge
Intervention | hours (Median) |
---|---|
Acetaminophen Injectable Product | 46.30 |
Sodium Chloride 0.9%, Intravenous | 64.66 |
The time it takes for the patient to be fully discharged from the hospital post-surgery will be measured. (NCT03198871)
Timeframe: From date of randomization until the date of hospital discharge or 30 days postoperatively, whichever comes first
Intervention | days (Median) |
---|---|
Acetaminophen Injectable Product | 4.08 |
Sodium Chloride 0.9%, Intravenous | 4.94 |
The time it takes for the patient to ingest orally post-surgery will be measured. (NCT03198871)
Timeframe: From date of randomization until the date of first documented oral intake, assessed up to 72 hours postoperatively
Intervention | hours (Median) |
---|---|
Acetaminophen Injectable Product | 12.15 |
Sodium Chloride 0.9%, Intravenous | 9.40 |
The time from PACU admission to PACU discharge to the floor will be measured. (NCT03198871)
Timeframe: From time of PACU admission until the time of discharge, assessed up to 24 hours postoperatively
Intervention | minutes (Median) |
---|---|
Acetaminophen Injectable Product | 129.00 |
Sodium Chloride 0.9%, Intravenous | 152.50 |
Overall patient satisfaction as well as satisfaction relating to pain management and cost analyses will be measured. These will be measured with a numerical rating scale (NRS) with 0- being worst satisfaction and 10 - best satisfaction. (NCT03198871)
Timeframe: These measurements will be taken at time of discharge up to 30 days, whichever comes first
Intervention | score on a scale (Median) | |
---|---|---|
Patient satisfaction score, overall | Patient Satisfaction score, pain management | |
Acetaminophen Injectable Product | 10 | 10 |
Sodium Chloride 0.9%, Intravenous | 10 | 10 |
Frequency of emesis and rescue antiemetic requirement will be documented (NCT03198871)
Timeframe: These will be evaluated from the time of PACU admission until 72 hours postoperatively.
Intervention | Participants (Count of Participants) | |
---|---|---|
Emesis incidence 0-72 hours | Antiemetic use | |
Acetaminophen Injectable Product | 12 | 31 |
Sodium Chloride 0.9%, Intravenous | 14 | 45 |
Nausea will be evaluated by nausea score from 0 to 10, with 0 equaling no nausea and 10 equaling the worst nausea imaginable. (NCT03198871)
Timeframe: These will be evaluated from the time of PACU admission until 72 hours postoperatively.
Intervention | score on a scale (Mean) | |||||
---|---|---|---|---|---|---|
Nausea score POD 1 (am visit) | Nausea score POD 1 (pm visit) | Nausea score POD 2 (am visit) | Nausea score POD 2 (pm visit) | Nausea score POD 3 (am visit) | Nausea score POD 3 (pm visit) | |
Acetaminophen Injectable Product | 1.13 | 0.49 | 0.71 | 0.55 | 0.32 | 0.56 |
Sodium Chloride 0.9%, Intravenous | 0.60 | 0.92 | 0.75 | 0.69 | 0.66 | 0.78 |
Survey to assess patient's overall health (via a combination of mental and physical health assessment) at 30 days post-discharge. Two summary scores are reported from the SF-12 - a mental component score (MCS-12) and a physical component score (PCS-12). The scores may be reported as Z-scores (difference compared to the population average, measured in standard deviations). The United States population average PCS-12 and MCS-12 are both 50 points. The United States population standard deviation is 10 points. So each 10 increment of 10 points above or below 50, corresponds to one standard deviation away from the average (NCT03198871)
Timeframe: These measurements will take place at 30-days post hospital discharge
Intervention | Z-scores (difference compared to the pop (Median) | |
---|---|---|
SF 12 Physical score | SF 12 Mental score | |
Acetaminophen Injectable Product | 38.72 | 54.02 |
Sodium Chloride 0.9%, Intravenous | 38.07 | 52.08 |
Rescue analgesia will be given according to institutional pain management protocol. Unit of Measure recorded as OME (Oral Morphine Equivalent) consumption in mg. (NCT03198871)
Timeframe: From time of PACU admission until the time of discharge and 72-hours postoperatively, whichever comes first
Intervention | mg (Median) | ||||
---|---|---|---|---|---|
0-24 hours | 24-48 hours | 48-72 hours | 0-48 hours | 0-72 hours | |
Acetaminophen Injectable Product | 27.4 | 31.3 | 30 | 74 | 105.00 |
Sodium Chloride 0.9%, Intravenous | 36 | 45 | 37.5 | 88.8 | 127.1 |
7 trials available for bupivacaine and Lung Diseases
Article | Year |
---|---|
Effect of preincisional epidural fentanyl and bupivacaine on postthoracotomy pain and pulmonary function.
Topics: Adult; Aged; Analgesia, Epidural; Analgesics, Opioid; Anesthetics, Local; Blood Glucose; Bupivacaine | 2010 |
Gallbladder bed irrigation with bupivacaine improves pulmonary functions after laparoscopic cholecystectomy.
Topics: Adult; Analysis of Variance; Anesthetics, Local; Bupivacaine; Cholecystectomy, Laparoscopic; Female; | 2010 |
Comparison between intermittent intravenous analgesia and intermittent paravertebral subpleural analgesia for pain relief after thoracotomy.
Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Double-Blind Method; Drug Administ | 2012 |
Gastric emptying in post-thoracotomy patients receiving a thoracic fentanyl-bupivacaine epidural infusion.
Topics: Aged; Aged, 80 and over; Analgesia, Epidural; Anesthetics, Combined; Anesthetics, Intravenous; Anest | 2002 |
Postoperative pulmonary complications. Epidural analgesia using bupivacaine and opioids versus parenteral opioids.
Topics: Abdomen; Adult; Aged; Analgesia, Epidural; Anesthesia, Epidural; Anesthesia, General; Bupivacaine; D | 1993 |
Continuous paravertebral extrapleural infusion for post-thoracotomy pain management.
Topics: Anesthesia, Epidural; Anesthetics, Local; Bupivacaine; Catheterization; Fentanyl; Forced Expiratory | 1999 |
Postoperative pain and pulmonary complications: comparison of three analgesic regimens.
Topics: Adolescent; Adult; Aged; Anesthesia, Epidural; Bupivacaine; Cholecystectomy; Female; Humans; Infusio | 1985 |
5 other studies available for bupivacaine and Lung Diseases
Article | Year |
---|---|
Comparison of cost and outcomes in patients receiving thoracic epidural versus liposomal bupivacaine for video-assisted thoracoscopic pulmonary resection.
Topics: Adult; Aged; Aged, 80 and over; Analgesia, Epidural; Anesthetics, Local; Bupivacaine; Delayed-Action | 2019 |
Invited commentary.
Topics: Analgesia, Epidural; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Carbon Dioxide; Double-Bli | 2010 |
Cardiovascular collapse after combined spinal anaesthesia and interscalene brachial plexus block.
Topics: Aged; Anesthesia, Spinal; Brachial Plexus; Bupivacaine; Femoral Neck Fractures; Fracture Fixation, I | 1995 |
Anaesthetic practice and postoperative pulmonary complications.
Topics: Adult; Age Factors; Aged; Anesthesia Recovery Period; Anesthesia, Conduction; Anesthesia, General; A | 1992 |
Continuous paravertebral block for postthoracotomy analgesia in children.
Topics: Adolescent; Analgesia; Bupivacaine; Catheterization, Peripheral; Child; Female; Gastroesophageal Ref | 1992 |